Literature DB >> 2574769

Osteoporosis in early ankylosing spondylitis: a primary pathological event?

R Will1, R Palmer, A K Bhalla, F Ring, A Calin.   

Abstract

Patients with severe ankylosing spondylitis of long duration often have spinal osteoporosis secondary to ankylosis and immobility. Bone mineral density of defined regions of the lumbar spine, femoral neck, and carpus was measured in 25 men who met accepted diagnostic criteria for ankylosing spondylitis but had early disease, with normal mobility and no, or very minor, radiological evidence of lumbar spine involvement. Compared with age-matched male controls, patients with ankylosing spondylitis had a significantly lower hydroxyapatite density in the lumbar spine (mean [SD] 0.82 g/cm2 [0.12] vs 0.91 g/cm2 [0.11]) and in the femoral neck (0.83 g/cm2 [0.11] vs 0.92 g/cm2 [0.11]). There was no significant difference in carpal bone mineralisation density. The pattern of bone loss in these patients indicates early loss of trabecular bone in ankylosing spondylitis, possibly from a systemic cause, but biochemical indices of calcium turnover were similar in patients and controls.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574769     DOI: 10.1016/s0140-6736(89)92932-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  49 in total

1.  Spondylodiscitis and pseudarthrosis in a patient with enteropathic spondyloarthropathy.

Authors:  A Calin; D Robertson
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

2.  Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis.

Authors:  Abdellah El Maghraoui; Saida Tellal; Souad Chaouir; Khalil Lebbar; Ahmed Bezza; Abderrazak Nouijai; Lahsen Achemlal; Sanaa Bouhssain; El Mostapha Derouiche
Journal:  Clin Rheumatol       Date:  2004-12-08       Impact factor: 2.980

3.  Bone mineral density in ankylosing spondylitis.

Authors:  A Sivri; S Kilinc; Y Gokce-Kutsal; M Ariyurek
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

4.  Risk factors for urolithiasis in patients with ankylosing spondylitis: a prospective case-control study.

Authors:  Emel Gönüllü; N Şule Yaşar Bilge; Döndü U Cansu; Müge Bekmez; Ahmet Musmul; Nevbahar Akçar; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Urolithiasis       Date:  2016-08-19       Impact factor: 3.436

5.  Bone mineral density in patients with symptoms suggestive of spondyloarthritis.

Authors:  M Forien; A Moltó; A Etcheto; M Dougados; C Roux; K Briot
Journal:  Osteoporos Int       Date:  2015-01-28       Impact factor: 4.507

Review 6.  Urolithiasis as an extraarticular manifestation of ankylosing spondylitis.

Authors:  Cengiz Korkmaz; Döndü Üsküdar Cansu; John A Sayer
Journal:  Rheumatol Int       Date:  2017-08-18       Impact factor: 2.631

7.  Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis.

Authors:  U Lange; J Teichmann; J Strunk; U Müller-Ladner; K L Schmidt
Journal:  Osteoporos Int       Date:  2005-09-20       Impact factor: 4.507

8.  Determinants of hyperkyphosis in patients with ankylosing spondylitis.

Authors:  D Vosse; D van der Heijde; R Landewé; P Geusens; H Mielants; M Dougados; S van der Linden
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

9.  Osteopenia in men with mild and severe ankylosing spondylitis.

Authors:  H J Baek; S W Kang; Y J Lee; K C Shin; E B Lee; C D Yoo; Y W Song
Journal:  Rheumatol Int       Date:  2004-10-05       Impact factor: 2.631

10.  Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis.

Authors:  H Franck; E Keck
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.